A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

January 19, 2025

Study Completion Date

May 23, 2025

Conditions

Major Depressive Disorder

Interventions

DRUG

LV232 40mg

oral

DRUG

Escitalopram 20 mg

oral

DRUG

LV232 60mg

oral

DRUG

LV232 20mg

oral

Trial Locations (1)

Shanghai Mental Health Center Ethics Committee, Shanghai

All Listed Sponsors

lead

Vigonvita Life Sciences

INDUSTRY

NCT06476509 - A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET | Biotech Hunter | Biotech Hunter